Skip to main content

Missouri Judge Upholds $4.7 Billion Talcum Verdict

Missouri Judge Upholds $4.7 Billion Talcum Verdict

Missouri Judge Upholds $4.7 Billion Talcum Verdict

Introduction

Judge Rex Burlison in Missouri’s 22nd Circuit Court, St. Louis, confirmed on Tuesday the $4.7 billion award for 22 plaintiffs who alleged that asbestos presence in Johnson & Johnson's talcum products causes ovarian cancer.

Even as the talcum giant strongly denies its products contain carcinogenic asbestos, the case concluded in July in Missouri, as the jury found documents affirming that the company was aware of the risks of talcum and falsely marketed the product.

As per jury's verdict, $550 million has been awarded to the plaintiffs as compensatory damages, and an additional $4.14 billion in punitive damages. Each plaintiff along with the families of 6 women who died of ovarian cancer has been awarded $25 million. The verdict was one of the largest involving Johnson & Johnson talcum powder litigation, which holds more than 10,000 claims. J&J vows to appeal Missouri court’s judgment soon. The talcum manufacturer also faces several claims regarding asbestos exposure causing mesothelioma, which is a rare form of cancer affecting the heart, lungs, and abdomen.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.